Elucidating the role of ATF6α as a critical pro-fibrogenic transcription factor in Hepatic Stellate Cells
阐明 ATF6α 作为肝星状细胞中关键的促纤维化转录因子的作用
基本信息
- 批准号:10653257
- 负责人:
- 金额:$ 11.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAddressAlgorithmsApoptosisApoptoticAutophagocytosisAutophagosomeCRISPR/Cas technologyCell SeparationCell SurvivalCellsCellular StressChromatinCicatrixCirrhosisDataData AnalysesData SetDegradation PathwayDepositionEndoplasmic ReticulumExcisionExhibitsExtracellular Matrix ProteinsExtracellular SpaceFibrosisGene ExpressionGenesGenetic TranscriptionGoalsHealthHepatic Stellate CellHepatocyteImpairmentIn VitroInjectionsLiverLiver FailureLiver FibrosisLiver diseasesMembraneMusMyofibroblastOlive oil preparationPatientsPersonsPhenotypePhysiologic OssificationPrevalenceProcessProcollagenProductionProtein BiosynthesisProtein SecretionProteinsRegulationResearch PersonnelRoleSamplingSecretory CellSignal TransductionStarvationStimulusStressTissuesTransforming Growth Factor betaUp-RegulationWorkactivating transcription factorcell typechromatin remodelingchronic liver injuryendoplasmic reticulum stressfibrogenesisglobal healthin vivoinsightliver functionliver injurymRNA sequencingmisfolded proteinnovelprogramsprotein degradationprotein foldingproteostasisreceptorresponsesensortherapeutically effectivetranscription factortranscriptome sequencing
项目摘要
Cirrhosis is a global health crisis that develops in response to chronic liver injury. Liver injury activates Hepatic
Stellate Cells (HSCs) which differentiate into fibrogenic myofibroblasts. Fibrogenic HSCs produce and secrete
vast amounts of matrix proteins that deposit into the extracellular space leading to fibrosis, and if unchecked,
cirrhosis. While fibrosis is reversible upon removal of injurious stimuli, no therapies effectively promote fibrosis
regression. Production of matrix proteins by fibrogenic HSCs leads to excess proteins in the endoplasmic
reticulum (ER), placing stress on the ER. ER stress initiates the Unfolded Protein Response (UPR), a signaling
cascade allowing HSCs to adapt to increased protein load and facilitate efficient protein folding and secretion.
If ER stress is unresolved, UPR signaling switches from adaptive to pro-apoptotic. We propose that targeting
mechanisms facilitating HSC adaptation to ER stress would promote HSC apoptosis and limit
fibrogenesis, leading to fibrosis regression in vivo. Preliminary data shows that Activating Transcription
Factor 6α (ATF6α), a transcription factor and effector of the UPR, is crucial for HSC activation and survival in
vitro and fibrogenesis in vivo; however, the mechanisms underlying this role are unknown. RNAseq performed
on ATF6αΔ/Δ HSCs isolated from mice following 4 weeks of CCl4 injection revealed dysregulation of genes
involved in ossificaiton, protein degradation, apoptotic signaling, chromatin remodeling, and cellular response
to starvation compared to HSCs isolated from WT mice. We hypothesize that ATF6α activates
profibrogenic transcriptional programs to promote adaption of fibrogenic HSCs to ER stress and HSC
survival. Aim 1 will investigate the role of the ATF6α-regulated genes involved in ossification identified by our
RNAseq on HSCs isolated from mice with CCl4-induced fibrosis. We will additionally use RNAseq/ATACseq to
understand the short-term transcriptional impact of ATF6α deletion in HSCs. These analyses will reveal
ATF6α-dependent changes in the transcriptional and chromatin landscapes that drive fibrogenesis. Aim 2 will
study how ATF6α promotes HSC survival through ER-phagy: selective autophagic degradation of the ER. ER-
phagy is critical for secretory cell survival but its role in HSCs and fibrogenesis is unknown. We show that ER-
phagic flux increases in activated HSCs. Furthermore, ER-phagy receptors are upregulated in cirrhotic livers
and activated HSCs, and this upregulation is ATF6α-dependent. Aim 2 will study how ER-phagy maintains ER
function and promotes HSC survival to drive fibrogenesis, how ATF6α promotes ER-phagic flux in activated
HSCs, and the mechanisms by which key ER-phagy receptors target unfolded and misfolded proteins for
degradation. Together, the proposed studies will establish ATF6α as a key profibrotic transcription
factor in HSCs, provide insight into fibrogenic transcription regulated by ATF6α during fibrogenesis,
and identify a critical pro-fibrogenic role for ER-phagy. These studies will help lay the groundwork for my
initial R01 application, facilitating my transition from K01 recipient to independent investigator.
肝硬化是因慢性肝损伤而引发的全球健康危机。肝损伤激活肝脏
星状细胞 (HSC) 分化为纤维化肌成纤维细胞。纤维化 HSC 产生和分泌
大量的基质蛋白沉积到细胞外空间导致纤维化,如果不加以控制,
肝硬化。虽然纤维化在去除有害刺激后是可逆的,但没有任何疗法可以有效促进纤维化
回归。纤维化 HSC 产生基质蛋白导致内质中蛋白过多
网状结构 (ER),对 ER 施加压力。内质网应激启动未折叠蛋白反应 (UPR),这是一种信号传导
级联使 HSC 能够适应增加的蛋白质负载并促进有效的蛋白质折叠和分泌。
如果 ER 应激未得到解决,UPR 信号传导就会从适应性转变为促凋亡。我们建议瞄准
促进 HSC 适应 ER 应激的机制将促进 HSC 凋亡并限制
纤维发生,导致体内纤维化消退。初步数据显示,激活转录
因子 6α (ATF6α) 是一种转录因子和 UPR 效应子,对于 HSC 的激活和存活至关重要。
体外和体内纤维形成;然而,这种作用的机制尚不清楚。进行 RNA 测序
注射 CCl4 4 周后,从小鼠体内分离出的 ATF6αΔ/Δ HSC 发现基因失调
参与骨化、蛋白质降解、细胞凋亡信号传导、染色质重塑和细胞反应
与从 WT 小鼠中分离的 HSC 相比,其对饥饿的抵抗力更强。我们假设 ATF6α 激活
促进纤维化 HSC 适应 ER 应激和 HSC 的促纤维化转录程序
生存。目标 1 将研究我们确定的 ATF6α 调节基因参与骨化的作用
对从 CCl4 诱导的纤维化小鼠中分离出的 HSC 进行 RNAseq。我们还将使用 RNAseq/ATACseq 来
了解 HSC 中 ATF6α 缺失的短期转录影响。这些分析将揭示
ATF6α 依赖性转录和染色质景观变化驱动纤维发生。目标2将
研究 ATF6α 如何通过 ER 吞噬促进 HSC 存活:ER 的选择性自噬降解。 ER-
吞噬对于分泌细胞的存活至关重要,但其在 HSC 和纤维形成中的作用尚不清楚。我们证明 ER-
活化的 HSC 中的吞噬通量增加。此外,ER-吞噬受体在肝硬化肝脏中上调
和激活的 HSC,这种上调是 ATF6α 依赖性的。目标 2 将研究 ER 吞噬如何维持 ER
功能并促进 HSC 存活以驱动纤维形成,ATF6α 如何促进活化的 ER 吞噬通量
HSC,以及关键 ER 吞噬受体靶向未折叠和错误折叠蛋白质的机制
降解。总之,拟议的研究将确立 ATF6α 作为关键的促纤维化转录
HSC 中的因子,深入了解纤维形成过程中 ATF6α 调节的纤维形成转录,
并确定 ER 吞噬的关键促纤维化作用。这些研究将有助于为我的
最初的 R01 申请,帮助我从 K01 接受者过渡到独立研究者。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Cellular, Molecular, and Pathologic Consequences of Stress on the Liver.
压力对肝脏的细胞、分子和病理后果。
- DOI:10.1016/j.ajpath.2023.07.003
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Maiers,JessicaL;Chakraborty,Sanjukta
- 通讯作者:Chakraborty,Sanjukta
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica L Maiers其他文献
Jessica L Maiers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica L Maiers', 18)}}的其他基金
Elucidating the Role and Regulation of Proteostasis in Hepatic Fibrogenesis
阐明蛋白质稳态在肝纤维形成中的作用和调节
- 批准号:
10718882 - 财政年份:2023
- 资助金额:
$ 11.89万 - 项目类别:
Elucidating the role of ATF6α as a critical pro-fibrogenic transcription factor in Hepatic Stellate Cells
阐明 ATF6α 作为肝星状细胞中关键的促纤维化转录因子的作用
- 批准号:
10526974 - 财政年份:2022
- 资助金额:
$ 11.89万 - 项目类别:
Identifying targetable mechanisms of TMEM38B/TRIC-B in liver fibrosis
鉴定 TMEM38B/TRIC-B 在肝纤维化中的靶向机制
- 批准号:
10216441 - 财政年份:2021
- 资助金额:
$ 11.89万 - 项目类别:
REGULATION OF HEPATIC FIBROGENEISS BY TANGO1
TANGO1 对肝纤维形成的调节
- 批准号:
10319558 - 财政年份:2018
- 资助金额:
$ 11.89万 - 项目类别:
Regulation of Hepatic Fibrogeneiss by TANGO1
TANGO1 对肝纤维形成的调节
- 批准号:
9447570 - 财政年份:2018
- 资助金额:
$ 11.89万 - 项目类别:
REGULATION OF HEPATIC FIBROGENEISS BY TANGO1
TANGO1 对肝纤维形成的调节
- 批准号:
10369343 - 财政年份:2018
- 资助金额:
$ 11.89万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Research Grant














{{item.name}}会员




